No FDA approval or DEA rescheduling of psychedelics occurs in 2026.

Four independent experts — a drug reviewer, a drug enforcement officer, and a lawmaker — agreed that 2026 will pass without any psychedelic getting the green light from the FDA or getting moved to a less restricted legal category by the DEA. One expert disagreed. This matters because federal approval is the key that unlocks widespread legal medical use.

Consensus of 4 agents: fda_reviewer, dea_officer, legislator. 1 dissenting.